| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4248752
[patent_doc_number] => 06136846
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-24
[patent_title] => 'Formulation for paclitaxel'
[patent_app_type] => 1
[patent_app_number] => 9/427153
[patent_app_country] => US
[patent_app_date] => 1999-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7662
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/136/06136846.pdf
[firstpage_image] =>[orig_patent_app_number] => 427153
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/427153 | Formulation for paclitaxel | Oct 24, 1999 | Issued |
Array
(
[id] => 1180576
[patent_doc_number] => 06740668
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-05-25
[patent_title] => 'Methods for inhibiting diabetic complications'
[patent_app_type] => B1
[patent_app_number] => 09/422615
[patent_app_country] => US
[patent_app_date] => 1999-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 57
[patent_figures_cnt] => 86
[patent_no_of_words] => 24943
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/740/06740668.pdf
[firstpage_image] =>[orig_patent_app_number] => 09422615
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/422615 | Methods for inhibiting diabetic complications | Oct 20, 1999 | Issued |
Array
(
[id] => 4287840
[patent_doc_number] => 06211144
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-03
[patent_title] => 'Stable concentrated insulin preparations for pulmonary delivery'
[patent_app_type] => 1
[patent_app_number] => 9/419668
[patent_app_country] => US
[patent_app_date] => 1999-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4090
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/211/06211144.pdf
[firstpage_image] =>[orig_patent_app_number] => 419668
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/419668 | Stable concentrated insulin preparations for pulmonary delivery | Oct 14, 1999 | Issued |
Array
(
[id] => 4350871
[patent_doc_number] => 06214874
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-10
[patent_title] => 'Treatment of HPV induced cancer using in situ application of two nordihydroguiaretic acid derivatives, tetramethyl NDGA M4N and tetraglycinal NDGA G4N'
[patent_app_type] => 1
[patent_app_number] => 9/418594
[patent_app_country] => US
[patent_app_date] => 1999-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 11
[patent_no_of_words] => 7747
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 4
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/214/06214874.pdf
[firstpage_image] =>[orig_patent_app_number] => 418594
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/418594 | Treatment of HPV induced cancer using in situ application of two nordihydroguiaretic acid derivatives, tetramethyl NDGA M4N and tetraglycinal NDGA G4N | Oct 14, 1999 | Issued |
Array
(
[id] => 4296206
[patent_doc_number] => 06197808
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-06
[patent_title] => 'Methods for treating hyperplasia'
[patent_app_type] => 1
[patent_app_number] => 9/418890
[patent_app_country] => US
[patent_app_date] => 1999-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2350
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/197/06197808.pdf
[firstpage_image] =>[orig_patent_app_number] => 418890
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/418890 | Methods for treating hyperplasia | Oct 14, 1999 | Issued |
Array
(
[id] => 1550920
[patent_doc_number] => 06399594
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-06-04
[patent_title] => 'Stabilized tibolone compositions'
[patent_app_type] => B2
[patent_app_number] => 09/403139
[patent_app_country] => US
[patent_app_date] => 1999-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3720
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/399/06399594.pdf
[firstpage_image] =>[orig_patent_app_number] => 09403139
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/403139 | Stabilized tibolone compositions | Oct 13, 1999 | Issued |
Array
(
[id] => 1206007
[patent_doc_number] => 06716858
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-04-06
[patent_title] => 'Methods for inhibiting diabetic complications'
[patent_app_type] => B1
[patent_app_number] => 09/416915
[patent_app_country] => US
[patent_app_date] => 1999-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 63
[patent_figures_cnt] => 102
[patent_no_of_words] => 30931
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/716/06716858.pdf
[firstpage_image] =>[orig_patent_app_number] => 09416915
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/416915 | Methods for inhibiting diabetic complications | Oct 12, 1999 | Issued |
Array
(
[id] => 1193236
[patent_doc_number] => 06730686
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-05-04
[patent_title] => 'Methods for inhibiting oxidative modification of proteins'
[patent_app_type] => B1
[patent_app_number] => 09/414877
[patent_app_country] => US
[patent_app_date] => 1999-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 76
[patent_figures_cnt] => 122
[patent_no_of_words] => 30464
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/730/06730686.pdf
[firstpage_image] =>[orig_patent_app_number] => 09414877
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/414877 | Methods for inhibiting oxidative modification of proteins | Oct 7, 1999 | Issued |
Array
(
[id] => 4407378
[patent_doc_number] => 06232346
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-15
[patent_title] => 'Composition for improvement of cellular nutrition and mitochondrial energetics'
[patent_app_type] => 1
[patent_app_number] => 9/414689
[patent_app_country] => US
[patent_app_date] => 1999-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 14
[patent_no_of_words] => 9454
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/232/06232346.pdf
[firstpage_image] =>[orig_patent_app_number] => 414689
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/414689 | Composition for improvement of cellular nutrition and mitochondrial energetics | Oct 6, 1999 | Issued |
Array
(
[id] => 4185084
[patent_doc_number] => 06159943
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-12
[patent_title] => 'Use of ribose to prevent cramping and soreness in muscles'
[patent_app_type] => 1
[patent_app_number] => 9/405464
[patent_app_country] => US
[patent_app_date] => 1999-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1850
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/159/06159943.pdf
[firstpage_image] =>[orig_patent_app_number] => 405464
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/405464 | Use of ribose to prevent cramping and soreness in muscles | Sep 23, 1999 | Issued |
Array
(
[id] => 4355527
[patent_doc_number] => 06218366
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-17
[patent_title] => 'Method for raising the hypoxic threshold'
[patent_app_type] => 1
[patent_app_number] => 9/406266
[patent_app_country] => US
[patent_app_date] => 1999-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7584
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/218/06218366.pdf
[firstpage_image] =>[orig_patent_app_number] => 406266
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/406266 | Method for raising the hypoxic threshold | Sep 23, 1999 | Issued |
| 09/397727 | USE OF INHIBITORS OF THE SODIUM-HYDROGEN EXCHANGER FOR THE PRODUCTION OF A MEDICAMENT FOR DECREASING UNDESIRED EFFECTS OF SUBSTRATES OF THE HEART | Sep 16, 1999 | Abandoned |
Array
(
[id] => 4305892
[patent_doc_number] => 06316038
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-13
[patent_title] => 'Therapeutic compositions'
[patent_app_type] => 1
[patent_app_number] => 9/397109
[patent_app_country] => US
[patent_app_date] => 1999-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15406
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/316/06316038.pdf
[firstpage_image] =>[orig_patent_app_number] => 397109
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/397109 | Therapeutic compositions | Sep 15, 1999 | Issued |
Array
(
[id] => 4273408
[patent_doc_number] => 06323237
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-27
[patent_title] => 'Therapeutic compositions'
[patent_app_type] => 1
[patent_app_number] => 9/397100
[patent_app_country] => US
[patent_app_date] => 1999-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16588
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/323/06323237.pdf
[firstpage_image] =>[orig_patent_app_number] => 397100
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/397100 | Therapeutic compositions | Sep 15, 1999 | Issued |
Array
(
[id] => 4296561
[patent_doc_number] => 06197832
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-06
[patent_title] => 'Composition for reducing serum cholesterol levels'
[patent_app_type] => 1
[patent_app_number] => 9/395524
[patent_app_country] => US
[patent_app_date] => 1999-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1416
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/197/06197832.pdf
[firstpage_image] =>[orig_patent_app_number] => 395524
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/395524 | Composition for reducing serum cholesterol levels | Sep 13, 1999 | Issued |
| 09/381126 | METHOD FOR TREATING SCHIZOPHRENIA | Sep 9, 1999 | Abandoned |
| 09/392747 | USE OF BENZENESULFONYL(THIO)UREAS FOR THE TREATMENT AND PROPHYLAXIS OF DYFUNCTIONS OF THE AUTONOMOUS NERVOUS SYSTEM AND USE OF BENZENESULFONYL(THIO)UREAS IN COMBINATION WITH BETA-RECEPTOR BLOCKERS | Sep 8, 1999 | Abandoned |
Array
(
[id] => 4156951
[patent_doc_number] => 06103757
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-15
[patent_title] => 'Methods for treating arrhythmia using acetate buffer solutions of amiodarone'
[patent_app_type] => 1
[patent_app_number] => 9/390295
[patent_app_country] => US
[patent_app_date] => 1999-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3386
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/103/06103757.pdf
[firstpage_image] =>[orig_patent_app_number] => 390295
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/390295 | Methods for treating arrhythmia using acetate buffer solutions of amiodarone | Sep 2, 1999 | Issued |
Array
(
[id] => 4252538
[patent_doc_number] => 06207690
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-27
[patent_title] => 'Troglitazone compounds for treating climacteric and cancer'
[patent_app_type] => 1
[patent_app_number] => 9/389828
[patent_app_country] => US
[patent_app_date] => 1999-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 14
[patent_no_of_words] => 11513
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/207/06207690.pdf
[firstpage_image] =>[orig_patent_app_number] => 389828
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/389828 | Troglitazone compounds for treating climacteric and cancer | Sep 2, 1999 | Issued |
| 09/385625 | ANTI-EMETIC COMPOSITION | Aug 25, 1999 | Abandoned |